Related Experiment Video
Updated: Jun 19, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Living with uncertainty: equivocal Pap test results and the evolution of ASC terminology
Lydia Pleotis Howell1, Maaya Wilton, John Bishop
1Department of Pathology and Laboratory Medicine, University of California, Davis School of Medicine, Sacramento, California 95817, USA. lydia.howell@ucdmc.ucdavis.edu
Abstract:
Communication of equivocal findings and their significance has been a significant challenge related to Pap testing throughout its history. Terminology to report these findings has changed considerably to accommodate the changes in understanding of cervical neoplasia, and to accommodate new management strategies, tests, and technologies. This article reviews the evolution of terminology for equivocal Pap test findings from the original Papanicolaou classification to the current the Bethesda System 2001 atypical squamous cells terminology, the implication and use of these terms, and the changing landscape of cervical neoplasia screening, which prompted these terminology changes. Emerging issues related to improving risk stratification through the introduction of additional terms and the impact of human papillomavirus testing may alter terminology of equivocal findings in the future.
Related Concept Videos
Cellular Adaptation IV: Dysplasia and Metaplasia
Uncertainty: Overview
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Cancer Survival Analysis